Filing Details
- Accession Number:
- 0001012975-15-000283
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-04-09 16:43:20
- Reporting Period:
- 2015-04-07
- Filing Date:
- 2015-04-09
- Accepted Time:
- 2015-04-09 16:43:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1488613 | Foundation Medicine Inc. | FMI | Services-Medical Laboratories (8071) | 271316416 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1319446 | Alexis Borisy | C/O Third Rock Ventures, Llc 29 Newbury Street, 3Rd Floor Boston MA 02116 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-04-07 | 234,542 | $50.00 | 56,093 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The amount reported represents the estimated number of shares sold by the reporting person in connection with the tender offer for shares of Common Stock of the Issuer (the "Tender Offer") by Roche Holdings, Inc. ("Roche"). Roche will purchase only a prorated portion of the shares properly tendered by each tendering stockholder. Based on a preliminary count reported by Roche, the preliminary proration factor for the Tender Offer is approximately 80.7%. An amended Form 4 will be filed to report the number of shares actually sold by the reporting person in connection with the Tender Offer once the final proration factor is determined.
Billionaire Hedge Funds
